Last Posted: Jul 24, 2020
- Combating opioid addiction and abuse-2 ways to effectively intervene in the cycle of addiction through pharmacogenomics.
J Marcalus Steven et al. Journal of the American Pharmacists Association : JAPhA 59(4) 469-473 - Pharmacogenomics in IVF: A New Era in the Concept of Personalized Medicine.
Kalinderi Kallirhoe et al. Reproductive sciences (Thousand Oaks, Calif.) 2019 26(10) 1313-1325 - Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
Athreya Arjun P et al. Clinical pharmacology and therapeutics 2019 106(4) 855-865 - Group-based pharmacogenetic prediction: is it feasible and do current NHS England ethnic classifications provide appropriate data?
Ingram Catherine J E et al. The pharmacogenomics journal 2020 Jul - Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial.
Shah-Williams Ebony et al. Frontiers in genetics 2020 11571 - Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.
Hessels Arno C et al. The pharmacogenomics journal 2020 Jul - Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Nguyen Tam T et al. Journal of clinical pharmacy and therapeutics 2020 Jul - The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort.
Al Ammari Maha et al. Scientific reports 2020 Jul 10(1) 11613 - Using pharmacogenomics and therapeutic drug monitoring to guide drug selection and dosing in outpatient mental health comprehensive medication management.
Brown Jacob T et al. The mental health clinician 2020 Jul 10(4) 254-258 - Influence of glutathione S transferase A1 gene polymorphism (-69C > T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis.
Attia Doaa H S et al. Clinical rheumatology 2020 Jul
.png)
No hay comentarios:
Publicar un comentario